Mice lacking the norepinephrine transporter are supersensitive to psychostimulants

Nature Neuroscience

Volumn 3, Issue 5, 2000, Pages 465-471

  Xu, Fei ^a   Gainetdinov, Raul R ^a   Wetsel, William C ^a   Jones, Sara R ^a   Bohn, Laura M ^a   Miller, Gary W ^a,b   Wang, Yan Min ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; CATECHOLAMINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; NORADRENALIN; PSYCHOSTIMULANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; LOCOMOTION; MOUSE; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR SENSITIVITY;

AMPHETAMINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE DELETION; HOMEOSTASIS; MESENCEPHALON; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SYMPORTERS; SYNAPTIC TRANSMISSION;

EID: 0033915420     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/74839     Document Type: Article

References (40)

1. Feldman, R. S., Meyer, J. S. & Quenzer, L. F. Principles of Neuropsychopharmacology 324-344 (Sinauer, Sunderland, Massachusetts, 1992).
2. Axelrod, J. & Kopin, I. J. The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves. Prog. Brain Res. 31, 21-32 (1969).
3. Lindvall, O. & Bjorklund, A. in Chemical Neuroanatomy (ed. Emson, P. C.) 229-255 (Raven, New York, 1983).
4. Amara, S. G. & Kuhar, M. J. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 73-93 (1993).
5. Giros, B. & Caron, M. G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49 (1993).
6. Pacholczyk, T., Blakely, R. D. & Amara, S. G. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354 (1991).
7. Fritz, J. D., Jayanthi, L. D., Thoreson, M. A. & Blakely, R. D. Cloning and chromosomal mapping of the murine norepinephrine transporter. J. Neurochem. 70, 2241-2251 (1998).
8. Markou, A., Kosten, T. R. & Koob, G. F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18, 135-174 (1998).
9. Robinson, T. E. & Berridge, K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291 (1993).
10. Jones, S. R. et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA 95, 4029-4034 (1998).
11. Gainetdinov, R. R., Jones, S. R., Fumagalli, F., Wightman, R. M. & Caron, M. G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res. Rev. 26, 148-153 (1998).
12. Jones, S. R. et al. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat. Neurosci. 2, 649-655 (1999).
13. Bengel, D. et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Mol. Pharmacol. 53, 649-655 (1998).
14. Wang, Y. M. et al. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19, 1285-1296 (1997).
15. Palij P. & Stamford, J. A. Real-time monitoring of endogenous noradrenaline release in rat brain slices using fast cyclic voltammetry: 1. Characterization of evoked noradrenaline efflux and uptake from nerve terminals in the bed nucleus of stria terminalis, pars ventralis. Brain Res. 587, 137-146 (1992).
16. Leonard, B. E. The role of noradrenaline in depression: a review. J. Psychopharmacol. 11, S39-S47 (1997).
17. Hornig, A. & Van Praag, H. M. Depression: Neurobiological, Psychopathological and Therapeutic Advances (Wiley, New York, 1997).
18. Porsolt, R. D., Bertin, A. & Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336 (1977).
19. Steru, L. et al. The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 11, 659-671 (1987).
20. Richelson, E. Synaptic effects of antidepressants. J. Clin. Psychopharmacol. 16, 1S-7S (1996).
21. Giros, B. et al. Delineation of discrete domains for substrate, cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985-15988 (1994).
22. Rossetti, Z. L., D'Aquila, P. S., Hmaidan, Y., Gessa, G. L. & Serra, G. Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation. Eur. J. Pharmacol. 201, 243-245 (1991).
23. Willner, P. The mesolimbic dopamine system as a target for rapid antidepressant action. Int. Clin. Psychopharmacol. 12 (Suppl. 3), S7-S14 (1997).
24. Spyraki, C. & Fibiger, H. C. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur. J. Pharmacol. 74, 195-206 (1981).
25. Nestler, E. J. & Aghajanian, G. K. Molecular and cellular basis of addiction. Science 278, 58-63 (1997).
26. Carr, G. D., Fibiger, H. C. & Phillips, A. G. in The Neuropharmacological Basis of Reward (eds. Liebman, J. M. & Cooper, S. J.) 265-319 (Clarendon, Oxford, 1989).
27. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612 (1996).
28. Rocha, B. A. et al. Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1, 132-137 (1998).
29. Sora, I. et al. Cocaine reward models: conditioned place preference can be established in dopamine-and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. USA 95, 7699-7704 (1998).
30. Reith, M. E. A. & Chen, N. in Neurotransmitter Transporters: Structure, Function and Regulation (ed. Reith, M. E. A.) 345-391 (Humana Press, Totowa, New Jersey, 1997).
31. Yavich, L., Lappalainen, R., Sirvio, J., Haapalinna, A. & MacDonald, E. Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur. J. Pharmacol. 339, 113-119 (1997).
32. Grenhoff, J. & Svensson, T. H. Clonidine modulates dopamine firing in rat ventral tegmental area. Eur. J. Pharmacol. 165, 11-18 (1989).
33. Cragg, S. J., Rice, M. E. & Greenfield, S. A. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area and striatum. J. Neurophysiol. 77, 863-873 (1997).
34. 3-type receptors as a final common pathway in antidepressant drug action. Clin. Neuropharmacol. 18 (Suppl. 1), S49-S56 (1995).
35. Mann, J. J. & Kapur, S. A dopaminergic hypothesis of major depression. Clin. Neuropharm. 18, S57-S65 (1995).
36. 3H]desipramine binding to rat brain tissue: binding to both noradrenaline uptake sites and sites not related to noradrenaline neurons. J. Neurochem. 52, 1099-1106 (1989).
37. Krobert, K. A., Sutton, R. L. & Feeney, D. M. Spontaneous and amphetamine-evoked release of cerebellar noradrenaline after sensimotor cortex contusion: an in vivo microdialysis study in the awake rat. J. Neurochem. 62, 2233-2240 (1994).
38. Gainetdinov, R. R. et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397-401 (1999).
39. Gong, W., Neill, D. & Justice, J. B. Jr. Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res. 707, 64-74 (1996)
40. 35S]GTPγS) binding in rat striatal membranes. Biochem. Pharmacol. 57, 155-162 (1999).